Gilead Exercises Option To License Nurix's Protein Degrader Molecule NX-0479

Biopharmaceutical companies Gilead Sciences, Inc. (GILD) and Nurix Therapeutics, Inc. (NRIX) announced Monday that Gilead has exercised its option to exclusively license Nurix's investigational targeted protein degrader molecule NX-0479.

This bivalent degrader, designated GS-6791, is the first development candidate resulting from the previously announced Nurix-Gilead collaboration to discover, develop, and commercialize a pipeline of innovative targeted protein degradation therapies.

Under the terms, for the NX-0479 option that Gilead is exercising, Nurix will receive an option exercise payment of $20 million and potentially could receive up to an additional $425 million in clinical, regulatory, and commercial milestone payments, as well as up to low double-digit tiered royalties on product net sales.

GS-6791 is a potent, selective, oral IRAK4 degrader that targets both the scaffold and kinase functions of the IRAK4 protein kinase to block inflammatory responses downstream of toll-like receptors (TLR) and the pro-inflammatory IL1 cytokine family of receptors (IL1Rs).

IRAK4 degradation has potential applications in the treatment of rheumatoid arthritis (RA) and other inflammatory diseases.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Naperville, Illinois-based Chervon North America Inc. is recalling EGO Power+ Cordless Brushless Hedge Trimmers citing laceration hazard, the U.S. Consumer Product Safety Commission said. The recall involves EGO Power+ Model HT2410 Cordless Brushless Hedge Trimmers that were manufactured prior to March 30, 2019. About 85,000 units were sold in the United States and about 4,000 units were sold... Paterson, New Jersey - based E.N.A. Meat Packing Inc. is recalling around 39,947 pounds of frozen, raw lamb products that were imported without the benefit of import reinspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The products subject to recall include cartons weighing around 40-lb., containing raw frozen pieces of "Simunovic S.A. Frozen Bon Retailers Macy's, Inc. (M) and Dollar General Corp. (DG) reported on Thursday that net profits for the first quarter declined from last year, with Macy's topping estimates, while Dollar General missed it. Net sales at both retailers missed expectations. Both Macy's and Dollar General also slashed their guidance for the full-year 2023.
Follow RTT